Brief: Baudax Bio Says Substantial Doubt Exists About Ability To Continue As A Going Concern For Next Twelve Months
Dec 13 (Reuters) - Baudax Bio Inc BXRX.PK :
* BAUDAX BIO INC - SUBSTANTIAL DOUBT EXISTS ABOUT OUR
ABILITY TO
CONTINUE AS A GOING CONCERN FOR THE NEXT TWELVE MONTHS
* BAUDAX BIO INC - CAPITAL RESOURCES ARE NOT SUFFICIENT TO
SUPPORT
OUR PLANNED OPERATIONS FOR THE NEXT TWELVE MONTHS FROM THE DATE
HEREOF
* BAUDAX BIO INC - EXPECT TO INCUR LOSSES FOR FORESEEABLE
FUTURE
AS WE CONTINUE OUR EFFORTS TO DEVELOP OUR CURRENT AND FUTURE
PRODUCT CANDIDATES
Source text for Eikon: [ID: https://bit.ly/48gi2Ey]
Further company coverage: BXRX.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Baudax Bio
See all newsBrief: Baudax Bio On Feb 22, Filed Voluntary Petition Under Chapter 11 Of U.S. Bankruptcy Code
Brief: Baudax Bio Says Substantial Doubt Exists About Ability To Continue As A Going Concern For Next Twelve Months
Baudax Bio Inc expected to post a loss of 53 cents a share - Earnings Preview
Brief: Baudax Bio Says Phase 1/2a Clinical Study of TI-168 In Hemophilia A with FVIII Inhibitors Projected to Begin Q1 2024
Brief: Baudax Bio Inc - On October 5, 2023, Board Of Directors Of Company Appointed Natalie Mcandrew As Interim Chief Financial Officer